US Stock MarketDetailed Quotes

ITOS ITeos Therapeutics

Watchlist
  • 8.540
  • +0.350+4.27%
Close Nov 27 16:00 ET
  • 8.540
  • 0.0000.00%
Post 16:20 ET
312.00MMarket Cap-2719P/E (TTM)

About ITeos Therapeutics Company

iTeos Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of a new generation of immuno-oncology therapeutics for people living with cancer. Its pipeline includes EOS-448, Inupadenant, and EOS-984. The company was founded by Michel Detheux in April 2012 and is headquartered in Watertown, MA.

Company Profile

SymbolITOS
Company NameITeos Therapeutics
Listing DateJul 24, 2020
Issue Price19.00
Founded2012
CEODr. Michel Detheux, PhD
MarketNASDAQ
Employees157
Fiscal Year Ends12-31
Address321 Arsenal Street
CityWatertown
ProvinceMassachusetts
CountryUnited States of America
Zip Code02472
Phone1-339-217-0162
Websitehttp://www.iteostherapeutics.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Michel Detheux, PhD
  • President, Chief Executive Officer and Director
  • 10.51M
  • Matthew Call
  • Chief Operating Officer
  • 2.86M
  • Matthew Gall
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Dr. Yvonne McGrath
  • Chief Scientific Officer
  • --
  • David L. Hallal
  • Chairman of the Board
  • 403.46K
  • Dr. Tony Ho, M.D.
  • Independent Director
  • 296.96K
  • Dr. Robert Iannone, M.D.
  • Independent Director
  • 297.96K
  • Jill DeSimone
  • Independent Director
  • --
  • Ann D. Rhoads
  • Independent Director
  • 309.46K
  • Tim Van Hauwermeiren, M. Sc.
  • Independent Director
  • 295.46K
  • David K. Lee
  • Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data